Archives: Agenda
PANEL DISCUSSION Meeting Notified Body expectations for clinical data in 2026
- Understand how notified body reviews differ by organization
- Learn what makes a CER or PMCF study “good enough” in practice
- Avoid overcommitting with evidence plans that are too ambitious
Session reserved for event sponsor
Session reserved for event sponsor
Morning refreshments and networking
Adapting trial designs to global market realities
- Align protocol design with MDR, FDA and global regulatory expectations
- Manage endpoint variability across geographies without undermining quality
- Avoid costly rework by building flexibility into trial strategy